Register Now
Course Information

Agenda

Networking Opportunities

With a full academic agenda, be sure to take time to enjoy networking during breaks and meals throughout the conference. Join us for the Conference social on Thursday, June 25, and abstract viewing and presentations on Thursday, June 25 and Friday, June 26.

Wednesday     Thursday     Friday     Saturday     

WEDNESDAY, JUNE 24, 2020 - PATHOBIOLOGY SYMPOSIUM

8:30 am
Registration
9:00 am
Welcome and Introductions

Pathogenesis of Granulomas

9:35 am
Noninfectious Granuloma Models
9:55 am
Infectious Models: Pathogenesis of Granulomas
10:15 am
Panel Discussion
10:30 am
Macrophage Plasticity in Granulomas
10:50 am
Adaptive Immunity in Sarcoidosis Granulomas
11:10 am
Role of Lymphatics in Granulomagenesis
11:30 am
Lumping and Splitting: Is IPF Just a Form of Progressive Pulmonary Fibrosis?
11:45 am
Break to Lunch
12:55 pm
Future of Pulmonary Fibrosis Treatment
1:30 pm
Refreshment Break and Exhibits

Fibrosis and Inflammation

2:00 pm
Mechanisms of Fibrosis in SSc
2:25 pm
Fibrosis and Metabolism
2:50 pm
Intersection Between Fibrosis and Inflammation
3:15 pm
Mechanisms of Granulomatous Fibrosis
3:40 pm
Panel Discussion
3:55 pm
Refreshment Break and Exhibits
4:25 pm
Genetics of Fibrosing Lung Disease
4:50 pm
Innate Immune Mechanisms in Fibrotic Lung Disease
5:15 pm
Role of Lymphocytes in Pulmonary Fibrosis
5:40 pm
Sex, Fibrosis and Inflammation
6:05 pm
Panel Discussion
6:20 pm
Adjourn

Back to top

8:15 am

THURSDAY JUNE 25, 2020

6:30 am
Registration & Breakfast
7:30 am
Welcome & Introductions

Sarcoidosis Genomics and Genetics

7:35 am
Precision Medicine in Sarcoidosis
7:55 am
Current State of Genetics and Genomics in Sarcoidosis
8:15 am
Gene-Environment Interactions
8:35 am
How Can Sarcoidosis Models Harness Genomic Approaches?
8:55 am
Biomarkers for Sarcoidosis: Current State and Future
9:15 am
Phenotyping for Genetic and Genomic Studies
9:35 am
Panel Discussion
9:55 am
Refreshment Break and Exhibits

Defining Disability in Sarcoidosis - WASOG Taskforce

10:20 am
Tools for Defining Disability in Chronic Disease
10:35 am
Patient Survey Results: Markers of Disability
10:50 am
Occupational Medicine Perspective on Disability
11:05 am
Small Group Discussions
11:30 am
Synopsis on Recommendations/ Votes
11:45 am
Break

Treatment

12:15 pm
ERS Treatment Guidelines
12:40 pm
WASOG SAPH Guidelines
1:05 pm
Adjourn to Lunch
4:30 pm
Meet the Professor Networking & Mentoring Session
5:30 pm
Poster Viewing/Exhibits
6:30 pm
Track 1 / Track 2

Track 1 - Pathobiology

6:30 pm
What Will Be the Next Therapies for Sarcoidosis?
 
6:50 pm
Common Features of and Differences Between Sarcoidosis and Berylliosis
 
7:10 pm
T-cell Epitopes in Sarcoidosis
 
7:30 pm
Epigenetic Regulation of CD4+ T Cells in Sarcoidosis
 
7:50 pm
Panel Discussion
 
8:10 pm
Adjourn

Track 2 - Epidemiology of Sarcoidosis Around the World

Americas
  • USA
  • Canada
  • Brazil
Europe
  • UK
  • Sweden
  • Serbia
  • Romania
  • Netherlands
  • France

Asia

  • Japan
  • India
  • China
  • Tatarstan
 
7:50 pm
Panel Discussion
 
8:10 pm
Adjourn
8:10 pm
Adjourn to Reception

Back to top

FRIDAY, JUNE 26, 2020

7:45 am
Registration

Imaging Research in Fibrotic Lung Disease: Applying Deep Learning to Unsolved Problems

8:20 am
Chest CT as an Integrative Biomarker of Sarcoidosis
8:40 am
Artificial Intelligence and Deep Learning Approaches
9:00 am
Deep Learning for Quantification
9:20 am
Clinical Context for Quantitative Imaging
9:40 am
Panel Discussion
10:05 am
Refreshment Break and Exhibits

Diagnosis of ILD

10:30 am
Should MDD be the Gold Standard for Assessing New Techniques: Pro/Con
11:05 am
Molecular Diagnosis of IIP
11:35 am
Novel Bronchoscopic Techniques for Diagnosis of ILD
11:55 am
Panel Discussion
12:05 pm
Break
12:15 pm
Antifibrotic Therapy for Non-IPF Interstitial Lung Disease
12:35 pm
Assessment of ILD in Clinical Practice
12:55 pm
Future of Clinical Trial Design in Fibrotic Lung Disease
1:20 pm
Panel Discussion
1:35 pm
Adjourn
4:30 pm
Consult the Professor Roundtables (bring your challenging cases to share with the experts)
5:15 pm
Oral Abstract Presentations
6:15 pm
Break

Interstitial Lung Abnormalities and Screening for ILD

6:45 pm
Assessment of Family Members in Patients with IPF
7:05 pm
Genetic Insights in ILA
7:25 pm
Biomarkers for ILA
7:45 pm
ILA Guideline Panel Report
8:05 pm
Panel Discussion
8:15 pm
Adjourn

Nursing Track Agenda
Taking Your Clinic to the Next Level:
A Special Symposium for Nurses, Research Coordinators, and Advanced Practice Providers


5 minutes for Q&A is included in each presentation
8:00 am
Welcome
8:05 am
Latest Updates – Epidemiology, Clinical Features and Outcomes
8:25 am
Why Does Sarcoidosis Happen? Latest Data on Etiology and Pathogenesis
8:45 am
What is Happening with Clinical Trials?  Novel and Upcoming Treatments
9:05 am
Panel Discussion
9:20 am
Evolving Treatment Paradigm for Sarcoidosis
9:40 am
Break
10:10 am
How to Educate Patients, Monitor and Manage Immunosuppressant Medications:
Interactive Document Review and Discussion
11:00 am
Individualizing Care: Demographic and Social Aspects for Best Outcomes
11:20 am
Using Patient Reported Outcomes in Your Clinic
11:40 am
Oxygen Devices
12:00 pm
Lunch
1:00 pm
Cardiac Sarcoidosis:  Features, Tests, Devices, and Medications
1:30 pm
Neurosarcoidosis and Small Fiber Neuropathy
2:00 pm
Multidimensional Approach to Symptoms in Your Patient: Interactive Document Review and Discussion
3:00 pm
Adjourn

Back to top

SATURDAY, JUNE 27, 2020

Diagnosis and Prognosis of Cardiac Sarcoidosis

7:30 am
MRI
7:50 am
FDG-PET
8:10 am
Diagnostic Tools in Suspected CS
8:30 am
Screening
8:50 am
Group Discussion
9:30 am
Break

Management Issues

9:45 am
Assessment of Electrophysiologic Abnormalities in CS
10:05 am
EPS Interventions for CS: When and How
10:25 am
Immunosuppressive Therapy for CS
10:45 am
Immunomodulation for Prevention of Myocardial Fibrosis
11:15 am
Panel Discussion
11:45 am
Lunch Break

Isolated Cardiac Sarcoidosis

12:15 pm
Isolated CS is Unusual: Pro/Con
12:45 pm
Definition of Cardiac Sarcoidosis
1:00 pm
Panel Discussion

WASOG Guidelines for Cardiac Sarcoidosis

1:15 pm
Defining Isolated CS: Task Force Recommendations
1:40 pm
Screening for Cardiac Sarcoidosis
2:05 pm
Treatment of Cardiac Sarcoidosis>
2:30 pm
Panel discussion
2:50 pm
Conference Summary
3:00 pm
Adjourn

Back to top